Literature DB >> 25600701

Glucosepane and oxidative markers in skin collagen correlate with intima media thickness and arterial stiffness in long-term type 1 diabetes.

Kari Anne Sveen1, Knut Dahl-Jørgensen2, Knut Haakon Stensaeth3, Kristin Angel4, Ingebjørg Seljeflot5, David R Sell6, Vincent M Monnier6, Kristian F Hanssen7.   

Abstract

AIMS: To study intima media thickness (cIMT) and arterial stiffness in type 1 diabetes of long duration, and their associations with the collagen cross-linker glucosepane and inflammatory and oxidative markers.
METHODS: Twenty-seven individuals with type 1 diabetes mellitus of 40 years duration from the Oslo Study cohort and 24 age-matched controls were included. cIMT measurements of the carotid artery were performed longitudinally. Pulse wave velocity (PWV), augmentation index (AIx) and augmentation pressure (AP) were assessed cross-sectionally. Glucosepane and the oxidative product methionine sulfoxide (MetSO) were determined in skin collagen by liquid chromatography-mass spectrometry. Circulating inflammatory markers were determined by ELISAs.
RESULTS: The diabetes patients had significantly increased cIMT and arterial stiffness compared to controls. Significant correlations were noted for skin glucosepane with cIMT (r=0.41) and PWV (r=0.44). Skin MetSO and monocyte chemoattractant protein-1 (MCP-1) correlated significantly with AIx and AP. After correcting for age and mean arterial pressure in multiple linear regression analysis, MetSO and MCP-1 were both independently associated with AIx and AP.
CONCLUSIONS: These results suggest more premature atherosclerosis and arterial pathology in individuals with diabetes compared to age-matched controls. They also suggest an association between the arterial pathology and markers of collagen crosslinking, oxidative damage and inflammation in type 1 diabetes patients of forty years disease duration.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arterial stiffness; Diabetes mellitus; Glucosepane; Methionine sulfoxide; Type 1

Mesh:

Substances:

Year:  2014        PMID: 25600701     DOI: 10.1016/j.jdiacomp.2014.12.011

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  8 in total

Review 1.  Paradigm Shifts in Ophthalmic Diagnostics.

Authors:  J Sebag; Alfredo A Sadun; Eric A Pierce
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

2.  Diet-Derived Advanced Glycation End Products (dAGEs) Induce Proinflammatory Cytokine Expression in Cardiac and Renal Tissues of Experimental Mice: Protective Effect of Curcumin.

Authors:  Boopathi Sowndhar Rajan; Kalaiselvi Krishnan; Elangovan Vellaichamy
Journal:  Cardiovasc Toxicol       Date:  2021-10-16       Impact factor: 3.231

Review 3.  Metabolomics of Arterial Stiffness.

Authors:  Kaido Paapstel; Jaak Kals
Journal:  Metabolites       Date:  2022-04-20

Review 4.  The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes.

Authors:  Vincent M Monnier; Saul Genuth; David R Sell
Journal:  Glycoconj J       Date:  2016-06-25       Impact factor: 2.916

Review 5.  The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality.

Authors:  Jyotiska Chaudhuri; Yasmin Bains; Sanjib Guha; Arnold Kahn; David Hall; Neelanjan Bose; Alejandro Gugliucci; Pankaj Kapahi
Journal:  Cell Metab       Date:  2018-09-04       Impact factor: 27.287

6.  Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function.

Authors:  Leif Brunvand; Martin Heier; Cathrine Brunborg; Kristian F Hanssen; Drude Fugelseth; Knut Haakon Stensaeth; Knut Dahl-Jørgensen; Hanna Dis Margeirsdottir
Journal:  BMC Cardiovasc Disord       Date:  2017-05-25       Impact factor: 2.298

7.  Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study.

Authors:  Kristine B Holte; Mona Svanteson; Kristian F Hanssen; Kari Anne Sveen; Ingebjørg Seljeflot; Svein Solheim; David R Sell; Vincent M Monnier; Tore Julsrud Berg
Journal:  PLoS One       Date:  2020-05-13       Impact factor: 3.240

8.  Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.

Authors:  Vincent M Monnier; Wanjie Sun; Xiaoyu Gao; David R Sell; Patricia A Cleary; John M Lachin; Saul Genuth
Journal:  Cardiovasc Diabetol       Date:  2015-09-05       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.